These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38928644)

  • 21. Clinical features analysis of Kawasaki disease with abdominal symptoms as the first manifestation.
    Yang P; Mao Z; Sun M; Guo J
    Eur J Pediatr; 2023 Sep; 182(9):4049-4057. PubMed ID: 37394531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns.
    Sadeghi P; Izadi A; Mojtahedi SY; Khedmat L; Jafari M; Afshin A; Yarahmadi P; Hosseinali Beigi E
    BMC Infect Dis; 2021 Apr; 21(1):368. PubMed ID: 33874899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
    Wu Y; Wang S; Zhou Y; Yang Y; Li S; Yin W; Ding Y
    PLoS One; 2023; 18(10):e0292653. PubMed ID: 37824465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD
    Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Albumin level and progression of coronary artery lesions in Kawasaki disease: A retrospective cohort study.
    Xia Y; Qiu H; Wen Z; Shi H; Yu H; Li J; Zhang Q; Wang J; Rong X; Wu R; Chu M
    Front Pediatr; 2022; 10():947059. PubMed ID: 36186633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.
    Takekoshi N; Kitano N; Takeuchi T; Suenaga T; Kakimoto N; Suzuki T; Kada TT; Shibuta S; Tachibana S; Murayama Y; Yamaga H; Suzuki H
    JAMA Netw Open; 2022 Jun; 5(6):e2216642. PubMed ID: 35696166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
    Li W; Zhang L; Wang Z; He X; Lin H; Wang Y; Yuan J; Xie X; Zhang X; Qin Y; Huang P
    Int J Clin Pract; 2022; 2022():2726686. PubMed ID: 35989868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risk factors for coronary artery lesions in children with Kawasaki disease].
    Li Y; Wang XM; Liu YL; Shi K; Yang YF; Guo YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):938-41. PubMed ID: 23234782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kawasaki disease in infants less than one year of age: an Italian cohort from a single center.
    Mastrangelo G; Cimaz R; Calabri GB; Simonini G; Lasagni D; Resti M; Trapani S
    BMC Pediatr; 2019 Sep; 19(1):321. PubMed ID: 31493782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Early diagnosis of Kawasaki disease complicated by coronary artery lesions].
    Hu XH; Xu SX; Luan Z
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):853-5. PubMed ID: 12919919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. White Blood Cell and Neutrophil Counts and Response to Intravenous Immunoglobulin in Kawasaki Disease.
    Muto T; Masuda Y; Numoto S; Kodama S; Yamakawa K; Takasu M; Hayakawa T; Miyata K; Miyamoto R; Akaihata M; Iwayama H; Kitagawa Y; Kurahashi H; Shimomura Y; Hori T; Okuda M; Agata H; Okumura A
    Glob Pediatr Health; 2019; 6():2333794X19884826. PubMed ID: 31696148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L; Yaping L; Xiufen H
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is it all about age? Clinical characteristics of Kawasaki disease in the extremely young: PeRA research group experience.
    Çakmak F; Demir F; Çakan M; Sonmez HE; Çağlayan Ş; Karadağ ŞG; Varlı YZ; Otar Yener G; Öztürk K; Sözeri B; Aktay Ayaz N
    Postgrad Med; 2022 May; 134(4):429-434. PubMed ID: 35324413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
    Song D; Yeo Y; Ha K; Jang G; Lee J; Lee K; Son C; Lee J
    Eur J Pediatr; 2009 Nov; 168(11):1315-21. PubMed ID: 19159953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
    Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for coronary artery lesions in children with Kawasaki disease.
    Duan J; Jiang H; Lu M
    Arch Argent Pediatr; 2020 Oct; 118(5):327-331. PubMed ID: 32924395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.